Quarterly report [Sections 13 or 15(d)]

Segment Information

v3.26.3
Segment Information
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
We view our operations and manage our business as one operating segment, and our chief operating decision maker (CODM) is our chief executive officer. The following table presents segment information for the periods presented (in thousands):
Three Months Ended September 30, Nine Months Ended September 30,
2026 2025 2026 2025
Total Revenues $ 80,890  $ 69,462  $ 218,411  $ 224,480 
Less:
Employee related expenses 21,258  18,547  65,690  56,666 
Commercial related expenses 9,444  6,303  23,568  18,915 
Outside clinical trial related expenses 12,626  3,759  26,962  11,362 
Cost of product sales 10,783  4,753  23,914  13,666 
Consultants and third-party services 5,191  4,133  13,422  10,751 
Other segment items 4,483  3,547  12,290  10,824 
Interest (income) expense and other, net (304) 800  (86) 3,183 
Provision for (benefit from) income taxes 4,224  (280) 13,522  154 
Segment income $ 13,185  $ 27,900  $ 39,129  $ 98,959 
There are no reconciling items or adjustments between segment income presented above and net income as presented in our statements of operations. The CODM does not review assets in evaluating the segment performance, accordingly, such information is not presented.
For details of revenues disaggregated by category, see “Note 3 – Revenues.”
Employee related expenses primarily consist of salaries, employee benefits, other employee related expenses and stock-based compensation expense. For additional details of stock-based compensation expense, see “Note 6 – Stock-Based Compensation.” Other segment items for the periods presented primarily consist of travel related expenses, business insurance, taxes and licenses, and subscription services.